ALT-P7

N/A

Report date: 2024/02/05 13:59:12

Base Information

Drug NameALT-P7
Drug Alias NameHM2-drug conjugateTrastuzumab-drug conjugate - Alteogen/3SBioALT-P7HM2-MMAE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Cleavable peptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTubulin polymerisation inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonistsTubulin inhibitors
TargetsTubulinReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMacauSouth KoreaHong Kong +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesAlteogen Inc
China Registration ClassN/A

Develop Information

Active Companies3sbio IncAlteogen IncShenyang Sunshine Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A